Polysaccharide Hemostatic Agents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511245301

Publication Date:

November 12, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

It is indicated for use in surgical procedures, including cardiac, vascular, orthopedic, spinal, neurological, gynecological, ENT and trauma surgery as an adjunct hemostat when control of bleeding from capillary, venous, or arteriolar vessels by pressure, ligature, and other conventional means is either ineffective or impractical.
The global market for Polysaccharide Hemostatic Agents was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Polysaccharide Hemostatic Agents, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Polysaccharide Hemostatic Agents by region & country, by Type, and by Application.
The Polysaccharide Hemostatic Agents market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polysaccharide Hemostatic Agents.
Market Segmentation
By Company
Starch Medical
EndoClot
CryoLife Inc.
Saikesaisi Holding Group
Guizhou Jinjiu Biotech
Segment by Type:
1g
3g
5g
Segment by Application
Hospital
Specialist Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Polysaccharide Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Polysaccharide Hemostatic Agents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Polysaccharide Hemostatic Agents in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Polysaccharide Hemostatic Agents Product Introduction
1.2 Global Polysaccharide Hemostatic Agents Market Size Forecast
1.2.1 Global Polysaccharide Hemostatic Agents Sales Value (2019-2030)
1.2.2 Global Polysaccharide Hemostatic Agents Sales Volume (2019-2030)
1.2.3 Global Polysaccharide Hemostatic Agents Sales Price (2019-2030)
1.3 Polysaccharide Hemostatic Agents Market Trends & Drivers
1.3.1 Polysaccharide Hemostatic Agents Industry Trends
1.3.2 Polysaccharide Hemostatic Agents Market Drivers & Opportunity
1.3.3 Polysaccharide Hemostatic Agents Market Challenges
1.3.4 Polysaccharide Hemostatic Agents Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Polysaccharide Hemostatic Agents Players Revenue Ranking (2023)
2.2 Global Polysaccharide Hemostatic Agents Revenue by Company (2019-2024)
2.3 Global Polysaccharide Hemostatic Agents Players Sales Volume Ranking (2023)
2.4 Global Polysaccharide Hemostatic Agents Sales Volume by Company Players (2019-2024)
2.5 Global Polysaccharide Hemostatic Agents Average Price by Company (2019-2024)
2.6 Key Manufacturers Polysaccharide Hemostatic Agents Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Polysaccharide Hemostatic Agents Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Polysaccharide Hemostatic Agents
2.9 Polysaccharide Hemostatic Agents Market Competitive Analysis
2.9.1 Polysaccharide Hemostatic Agents Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Polysaccharide Hemostatic Agents Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polysaccharide Hemostatic Agents as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 1g
3.1.2 3g
3.1.3 5g
3.2 Global Polysaccharide Hemostatic Agents Sales Value by Type
3.2.1 Global Polysaccharide Hemostatic Agents Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Polysaccharide Hemostatic Agents Sales Value, by Type (2019-2030)
3.2.3 Global Polysaccharide Hemostatic Agents Sales Value, by Type (%) (2019-2030)
3.3 Global Polysaccharide Hemostatic Agents Sales Volume by Type
3.3.1 Global Polysaccharide Hemostatic Agents Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Polysaccharide Hemostatic Agents Sales Volume, by Type (2019-2030)
3.3.3 Global Polysaccharide Hemostatic Agents Sales Volume, by Type (%) (2019-2030)
3.4 Global Polysaccharide Hemostatic Agents Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Specialist Clinic
4.1.3 Other
4.2 Global Polysaccharide Hemostatic Agents Sales Value by Application
4.2.1 Global Polysaccharide Hemostatic Agents Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Polysaccharide Hemostatic Agents Sales Value, by Application (2019-2030)
4.2.3 Global Polysaccharide Hemostatic Agents Sales Value, by Application (%) (2019-2030)
4.3 Global Polysaccharide Hemostatic Agents Sales Volume by Application
4.3.1 Global Polysaccharide Hemostatic Agents Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Polysaccharide Hemostatic Agents Sales Volume, by Application (2019-2030)
4.3.3 Global Polysaccharide Hemostatic Agents Sales Volume, by Application (%) (2019-2030)
4.4 Global Polysaccharide Hemostatic Agents Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Polysaccharide Hemostatic Agents Sales Value by Region
5.1.1 Global Polysaccharide Hemostatic Agents Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Polysaccharide Hemostatic Agents Sales Value by Region (2019-2024)
5.1.3 Global Polysaccharide Hemostatic Agents Sales Value by Region (2025-2030)
5.1.4 Global Polysaccharide Hemostatic Agents Sales Value by Region (%), (2019-2030)
5.2 Global Polysaccharide Hemostatic Agents Sales Volume by Region
5.2.1 Global Polysaccharide Hemostatic Agents Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Polysaccharide Hemostatic Agents Sales Volume by Region (2019-2024)
5.2.3 Global Polysaccharide Hemostatic Agents Sales Volume by Region (2025-2030)
5.2.4 Global Polysaccharide Hemostatic Agents Sales Volume by Region (%), (2019-2030)
5.3 Global Polysaccharide Hemostatic Agents Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Polysaccharide Hemostatic Agents Sales Value, 2019-2030
5.4.2 North America Polysaccharide Hemostatic Agents Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Polysaccharide Hemostatic Agents Sales Value, 2019-2030
5.5.2 Europe Polysaccharide Hemostatic Agents Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Polysaccharide Hemostatic Agents Sales Value, 2019-2030
5.6.2 Asia Pacific Polysaccharide Hemostatic Agents Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Polysaccharide Hemostatic Agents Sales Value, 2019-2030
5.7.2 South America Polysaccharide Hemostatic Agents Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Polysaccharide Hemostatic Agents Sales Value, 2019-2030
5.8.2 Middle East & Africa Polysaccharide Hemostatic Agents Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Polysaccharide Hemostatic Agents Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Polysaccharide Hemostatic Agents Sales Value
6.2.1 Key Countries/Regions Polysaccharide Hemostatic Agents Sales Value, 2019-2030
6.2.2 Key Countries/Regions Polysaccharide Hemostatic Agents Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Polysaccharide Hemostatic Agents Sales Value, 2019-2030
6.3.2 United States Polysaccharide Hemostatic Agents Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Polysaccharide Hemostatic Agents Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Polysaccharide Hemostatic Agents Sales Value, 2019-2030
6.4.2 Europe Polysaccharide Hemostatic Agents Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Polysaccharide Hemostatic Agents Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Polysaccharide Hemostatic Agents Sales Value, 2019-2030
6.5.2 China Polysaccharide Hemostatic Agents Sales Value by Type (%), 2023 VS 2030
6.5.3 China Polysaccharide Hemostatic Agents Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Polysaccharide Hemostatic Agents Sales Value, 2019-2030
6.6.2 Japan Polysaccharide Hemostatic Agents Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Polysaccharide Hemostatic Agents Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Polysaccharide Hemostatic Agents Sales Value, 2019-2030
6.7.2 South Korea Polysaccharide Hemostatic Agents Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Polysaccharide Hemostatic Agents Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Polysaccharide Hemostatic Agents Sales Value, 2019-2030
6.8.2 Southeast Asia Polysaccharide Hemostatic Agents Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Polysaccharide Hemostatic Agents Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Polysaccharide Hemostatic Agents Sales Value, 2019-2030
6.9.2 India Polysaccharide Hemostatic Agents Sales Value by Type (%), 2023 VS 2030
6.9.3 India Polysaccharide Hemostatic Agents Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Starch Medical
7.1.1 Starch Medical Company Information
7.1.2 Starch Medical Introduction and Business Overview
7.1.3 Starch Medical Polysaccharide Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Starch Medical Polysaccharide Hemostatic Agents Product Offerings
7.1.5 Starch Medical Recent Development
7.2 EndoClot
7.2.1 EndoClot Company Information
7.2.2 EndoClot Introduction and Business Overview
7.2.3 EndoClot Polysaccharide Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.2.4 EndoClot Polysaccharide Hemostatic Agents Product Offerings
7.2.5 EndoClot Recent Development
7.3 CryoLife Inc.
7.3.1 CryoLife Inc. Company Information
7.3.2 CryoLife Inc. Introduction and Business Overview
7.3.3 CryoLife Inc. Polysaccharide Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.3.4 CryoLife Inc. Polysaccharide Hemostatic Agents Product Offerings
7.3.5 CryoLife Inc. Recent Development
7.4 Saikesaisi Holding Group
7.4.1 Saikesaisi Holding Group Company Information
7.4.2 Saikesaisi Holding Group Introduction and Business Overview
7.4.3 Saikesaisi Holding Group Polysaccharide Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Saikesaisi Holding Group Polysaccharide Hemostatic Agents Product Offerings
7.4.5 Saikesaisi Holding Group Recent Development
7.5 Guizhou Jinjiu Biotech
7.5.1 Guizhou Jinjiu Biotech Company Information
7.5.2 Guizhou Jinjiu Biotech Introduction and Business Overview
7.5.3 Guizhou Jinjiu Biotech Polysaccharide Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Guizhou Jinjiu Biotech Polysaccharide Hemostatic Agents Product Offerings
7.5.5 Guizhou Jinjiu Biotech Recent Development
8 Industry Chain Analysis
8.1 Polysaccharide Hemostatic Agents Industrial Chain
8.2 Polysaccharide Hemostatic Agents Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Polysaccharide Hemostatic Agents Sales Model
8.5.2 Sales Channel
8.5.3 Polysaccharide Hemostatic Agents Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Starch Medical
EndoClot
CryoLife Inc.
Saikesaisi Holding Group
Guizhou Jinjiu Biotech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂